Get the Stockscreener App
7.25
5.97%
-0.46
After Hours:
7.25
Kura Oncology Inc Stock (KURA) Latest News
FY2025 EPS Estimate for Kura Oncology Reduced by Analyst - Defense World
HC Wainwright Predicts Kura Oncology Q2 Earnings - Defense World
Wedbush Estimates Kura Oncology’s Q1 Earnings (NASDAQ:KURA) - Defense World
Kura Oncology’s (KURA) Outperform Rating Reiterated at Wedbush - Defense World
HC Wainwright Weighs in on Kura Oncology Q1 Earnings - Armenian Reporter
Brokers Offer Predictions for Kura Oncology Q1 Earnings - Armenian Reporter
Kura Oncology, Inc. to Host Earnings Call - ACCESS Newswire
Kura Oncology’s Financial Future at Risk: Dependency on Kyowa Kirin for Ziftomenib Development Raises Concerns - TipRanks
Research Analysts Set Expectations for Kura Oncology Q1 Earnings - MarketBeat
Equities Analysts Issue Forecasts for Kura Oncology Q1 Earnings - Defense World
Kura Oncology (NASDAQ:KURA) Stock Rating Upgraded by StockNews.com - Defense World
Kura Oncology (NASDAQ:KURA) Upgraded at StockNews.com - MarketBeat
Kura Oncology (NASDAQ:KURA) Earns Outperform Rating from Wedbush - MarketBeat
Kura Oncology (NASDAQ:KURA) Earns Buy Rating from HC Wainwright - MarketBeat
Kura Oncology (NASDAQ:KURA) shareholders have endured a 64% loss from investing in the stock a year ago - Yahoo Finance
Kura Oncology’s Positive Earnings Call Highlights Progress and Prospects - TipRanks
Kura Oncology (NASDAQ:KURA) Releases Earnings Results, Beats Estimates By $0.43 EPS - MarketBeat
Investor Network: Kura Oncology, Inc. to Host Earnings Call - ACCESS Newswire
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2024 Earnings Call Transcript - Insider Monkey
Kura Oncology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Kura Oncology’s Promising Path to FDA Approval: Analyst Recommends ‘Buy’ Following Positive Phase II Results and Strategic Advancements - TipRanks
Kura Oncology Inc (KURA) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Growth - Yahoo Finance
Kura Oncology Inc (KURA) Q4 2024 Earnings Call Highlights: Strat - GuruFocus.com
Kura Oncology’s Strategic Advancements and Financial Health Drive Buy Rating - TipRanks
Kura Oncology: Q4 Earnings Snapshot - The Washington Post
Kura Oncology Advances Cancer Drug Development - TipRanks
Kura Oncology Inc earnings beat by $0.35, revenue topped estimates - Investing.com
Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Kura Oncology: Q4 Earnings Snapshot -February 26, 2025 at 04:42 pm EST - Marketscreener.com
Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Can Kura Oncology's Breakthrough AML Treatment Reshape the Blood Cancer Market? - StockTitan
Kura Oncology to Participate in Three Upcoming Investor Conferences - The Manila Times
Can Kura Oncology's Conference Circuit Reveal New Cancer Treatment Breakthroughs? - StockTitan
Kura Oncology (KURA) Projected to Post Earnings on Wednesday - Defense World
Kura Oncology (KURA) to Release Quarterly Earnings on Wednesday - MarketBeat
Analysts Set Kura Oncology, Inc. (NASDAQ:KURA) PT at $27.13 - MarketBeat
Kura Oncology to Report Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Will Kura Oncology's Q4 Earnings Reveal New Cancer Drug Progress? - StockTitan
Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Weekly Investment Analysts’ Ratings Updates for Kura Oncology (KURA) - Defense World
Kura Oncology's SWOT analysis: stock poised for pivotal year ahead - MSN
Kura Oncology's SWOT analysis: stock poised for pivotal year ahead By Investing.com - Investing.com Canada
Barclays PLC Acquires 84,563 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - MarketBeat
FY2029 Earnings Forecast for Kura Oncology Issued By Wedbush - MarketBeat
Leerink Partnrs Estimates Kura Oncology Q1 Earnings - MarketBeat
Jennison Associates LLC Purchases New Holdings in Kura Oncology, Inc. (NASDAQ:KURA) - MarketBeat
BTIG Research Downgrades Kura Oncology (NASDAQ:KURA) to Neutral - MarketBeat
Kura Oncology (NASDAQ:KURA) Stock Price Expected to Rise, Wedbush Analyst Says - MarketBeat
Kura Oncology (NASDAQ:KURA) Shares Gap DownHere's What Happened - MarketBeat
Kura Oncology's (KURA) Market Outperform Rating Reaffirmed at JMP Securities - MarketBeat
Kura Oncology (NASDAQ:KURA) Price Target Raised to $40.00 - MarketBeat
Barclays PLC Buys 84,563 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Leerink Partnrs Predicts Kura Oncology Q1 Earnings - Defense World
A History of Outperforming Analyst Forecasts and Beating the Odds: Kura Oncology Inc (KURA) - SETE News
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):